OpenAI restructure plan gets SoftBank blessing as AI startup reportedly renegotiates Microsoft terms

OpenAI restructure plan gets SoftBank blessing as AI startup reportedly renegotiates Microsoft terms


OpenAI CEO Sam Altman speaks next to SoftBank CEO Masayoshi Son after U.S. President Donald Trump delivered remarks on AI infrastructure at the Roosevelt Room in the White House in Washington on Jan. 21, 2025.

Carlos Barria | Reuters

OpenAI said last week that it would restructure in a format that allows its non-profit entity to retain ultimate control, a plan that on Tuesday received the blessing of one of the U.S. artificial intelligence startup’s biggest backers — Japanese giant SoftBank.

The endorsement of SoftBank — the first time the company has publicly green lit the plan — is key because the Japanese firm’s $30 billion investment in OpenAI announced this year was contingent on a change in structure.

In March, OpenAI closed a $40 billion funding round, receiving $30 billion from SoftBank. But if OpenAI doesn’t restructure into a for-profit entity by Dec. 31, SoftBank has previously said it could reduce its portion of the financing to $20 billion.

OpenAI announced this month that it would not fully turn into a for-profit entity after pressure from civic leaders and former employees. Instead, the non-profit arm would retain control of the company, while the limited liability company, which handles all of the business operations, would turn into a public benefit corporation. That means this division will have the ability to generate profit, but will also focus on social good.

The AI startup was originally looking to remove the control of the non-profit, a plan that drew criticism from many in the tech space, including rival and initial OpenAI co-founder Elon Musk.

Since the non-profit would retain control, and the original restructure plan was ditched, it was unclear if OpenAI’s major investors were on board.

But SoftBank’s finance chief Yoshimitsu Goto said during an earnings press conference on Tuesday that “nothing has really changed.”

“I don’t think that’s the wrong direction … that’s something that we expected,” Goto said, according to a company translation of his comments in Japanese.

He reiterated that OpenAI needs to complete the restructure by the end of this year.

There could still be stumbling blocks along the way. Microsoft, one of OpenAI’s biggest investors, has not approved the restructure, according to a Bloomberg report earlier this month. The Financial Times on Sunday reported that OpenAI and Microsoft are rewriting the terms of their multibillion-dollar partnership. Microsoft is the key holdout to OpenAI’s restructure plan, the FT added.

SoftBank’s Goto did not mention any other companies, but acknowledged that OpenAI has many stakeholders.

“Our conversation is based on the assumption that the reorganization will take place. There are different staekholders however and some people may intervene in this project and this may not go as smooth as we hope,” Goto said.

“But that’s out of our control. We will wait and see what happens.”



Source

Stock futures are little changed as Wall Street eyes latest developments in Middle East and oil prices: Live updates
World

Stock futures are little changed as Wall Street eyes latest developments in Middle East and oil prices: Live updates

A trading floor manager works on the floor of the American Stock Exchange (AMEX) at the New York Stock Exchange (NYSE) in New York, US, on Monday, May 4, 2026. Michael Nagle | Bloomberg | Getty Images U.S. stock futures were little changed on Monday night after the major averages suffered declines amid growing concerns […]

Read More
CNBC’s The China Connection newsletter: China is rewiring the Silicon Valley model — starting in Hong Kong
World

CNBC’s The China Connection newsletter: China is rewiring the Silicon Valley model — starting in Hong Kong

Hi, this is Evelyn, writing to you from Beijing. Welcome to the latest edition of The China Connection — a succinct snapshot of what I’m seeing and hearing from local businesses. My latest conversations with investors reveal a notable shift: China has taken note of how finance powered Silicon Valley’s rise and is following suit. […]

Read More
Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly’s GLP-1 dominance
World

Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly’s GLP-1 dominance

Still life of the new Wegovy semaglutide tablets on a white background. Its a prescription medicine used with a reduced calorie diet and .and physical activity. Michael Siluk | Universal Images Group | Getty Images When the Wegovy pill launched in January, telehealth provider LifeMD said its business doubled almost overnight.  LifeMD went from seeing […]

Read More